Works matching AU Ferrannini, Ele

Results: 293

Differences in β-cell function and insulin secretion in Black vs. White obese adolescents: do incretin hormones play a role?

Published in:

Pediatric Diabetes, 2017, v. 18, n. 2, p. 143, doi. 10.1111/pedi.12364

By:

Michaliszyn, Sara F;
Lee, SoJung;
Bacha, Fida;
Tfayli, Hala;
Farchoukh, Lama;
Mari, Andrea;
Ferrannini, Ele;
Arslanian, Silva

Publication type:

Article

Increase of Interferon-γ Inducible CXCL9 and CXCL11 Serum Levels in Patients with Active Graves' Disease and Modulation by Methimazole Therapy.

Published in:

Thyroid, 2013, v. 23, n. 11, p. 1461, doi. 10.1089/thy.2012.0485

By:

Antonelli, Alessandro;
Ferrari, Silvia Martina;
Corrado, Alda;
Ferrannini, Ele;
Fallahi, Poupak

Publication type:

Article

Thyroid Cancer in HCV-Related Chronic Hepatitis Patients: A Case-Control Study.

Published in:

Thyroid, 2007, v. 17, n. 5, p. 447, doi. 10.1089/thy.2006.0194

By:

Alessandro Antonelli;
Clodoveo Ferri;
Poupak Fallahi;
Alessandro Pampana;
Silvia Martina Ferrari;
Lucio Barani;
Santino Marchi;
Ele Ferrannini

Publication type:

Article

Thyroid Disorders in Chronic Hepatitis C Virus Infection.

Published in:

Thyroid, 2006, v. 16, n. 6, p. 563

By:

Alessandro Antonelli;
Clodoveo Ferri;
Poupak Fallahi;
Silvia Martina Ferrari;
Alessandra Ghinoi;
Mario Rotondi;
Ele Ferrannini

Publication type:

Article

Role of Neck Ultrasonography in the Follow-Up of Children Operated on for Thyroid Papillary Cancer.

Published in:

Thyroid, 2003, v. 13, n. 5, p. 479

By:

Alessandro Antonelli;
Paolo Miccoli;
Poupak Fallahi;
Mariano Grosso;
Claudia Nesti;
Claudio Spinelli;
Ele Ferrannini

Publication type:

Article

Blocking the renin-angiotensin-aldosterone system to prevent diabetes mellitus.

Published in:

Diabetes & Vascular Disease Research, 2008, v. 5, n. 1, p. 59, doi. 10.3132/dvdr.2008.011

By:

McGuire, Darren K;
Winterfield, Jeffrey R;
Rytlewski, Jason A;
Ferrannini, Ele

Publication type:

Article

Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes.

Published in:

European Heart Journal, 2015, v. 36, n. 34, p. 2288, doi. 10.1093/eurheartj/ehv239

By:

Ferrannini, Ele;
DeFronzo, Ralph A.

Publication type:

Article

Age, Renal Dysfunction, Cardiovascular Disease, and Antihyperglycemic Treatment in Type 2 Diabetes Mellitus: Findings from the Renal Insufficiency and Cardiovascular Events Italian Multicenter Study.

Published in:

Journal of the American Geriatrics Society, 2013, v. 61, n. 8, p. 1253, doi. 10.1111/jgs.12381

By:

Solini, Anna;
Penno, Giuseppe;
Bonora, Enzo;
Fondelli, Cecilia;
Orsi, Emanuela;
Trevisan, Roberto;
Vedovato, Monica;
Cavalot, Franco;
Cignarelli, Mauro;
Morano, Susanna;
Ferrannini, Ele;
Pugliese, Giuseppe

Publication type:

Article

SGLT2 Inhibitor Dapagliflozin Increases Skeletal Muscle and Brain Fatty Acid Uptake in Individuals With Type 2 Diabetes: A Randomized Double-Blind Placebo-Controlled Positron Emission Tomography Study.

Published in:

Diabetes Care, 2024, v. 47, n. 9, p. 1630, doi. 10.2337/dc24-0470

By:

Latva-Rasku, Aino;
Rebelos, Eleni;
Tuisku, Jouni;
Aarnio, Richard;
Bhowmik, Achol;
Keskinen, Helmi;
Laurila, Sanna;
Lahesmaa-Hatting, Minna;
Pekkarinen, Laura;
Isackson, Henrik;
Kirjavainen, Anna K.;
Koffert, Jukka;
Heurling, Kerstin;
Nummenmaa, Lauri;
Ferrannini, Ele;
Oldgren, Jonas;
Oscarsson, Jan;
Nuutila, Pirjo

Publication type:

Article

High Mannose Correlates With Surrogate Indexes of Insulin Resistance and Is Associated With an Increased Risk of Cardiovascular Events Independently of Glycemic Status and Traditional Risk Factors.

Published in:

Diabetes Care, 2024, v. 47, n. 2, p. 246, doi. 10.2337/dc23-0870

By:

Fortin, Elena;
Campi, Beatrice;
Ferrannini, Ele;
Mari, Andrea;
Mellbin, Linda G.;
Norhammar, Anna;
Näsman, Per;
Rydén, Lars;
Saba, Alessandro;
Ferrannini, Giulia

Publication type:

Article

Metabolic, Intestinal, and Cardiovascular Effects of Sotagliflozin Compared With Empagliflozin in Patients With Type 2 Diabetes: A Randomized, Double-Blind Study.

Published in:

2022

By:

Posch, Maximilian G.;
Walther, Niklas;
Ferrannini, Ele;
Powell, David R.;
Banks, Phillip;
Wason, Suman;
Dahmen, Raphael

Publication type:

journal article

Fasting Substrate Concentrations Predict Cardiovascular Outcomes in the CANagliflozin cardioVascular Assessment Study (CANVAS).

Published in:

2022

By:

Ferrannini, Ele;
Baldi, Simona;
Scozzaro, Tiziana;
Tsimihodimos, Vasilis;
Tesfaye, Fisseha;
Shaw, Wayne;
Rosenthal, Norman;
Figtree, Gemma A.;
Neal, Bruce;
Mahaffey, Kenneth W.;
Perkovic, Vlado;
Hansen, Michael K.

Publication type:

journal article

New Insights on the Interactions Between Insulin Clearance and the Main Glucose Homeostasis Mechanisms.

Published in:

2021

By:

Bizzotto, Roberto;
Tricò, Domenico;
Natali, Andrea;
Gastaldelli, Amalia;
Muscelli, Elza;
De Fronzo, Ralph A.;
Arslanian, Silva;
Ferrannini, Ele;
Mari, Andrea

Publication type:

journal article

Response to Comment on Ferrannini and Rosenstock. Clinical Translation of Cardiovascular Outcome Trials in Type 2 Diabetes: Is There More or Is There Less Than Meets the Eye? Diabetes Care 2021;44:641-646.

Published in:

2021

By:

Ferrannini, Ele;
Rosenstock, Julio

Publication type:

Letter

Erratum. Clinical Translation of Cardiovascular Outcome Trials in Type 2 Diabetes: Is There More or Is There Less Than Meets the Eye? Diabetes Care 2031;44:641-646.

Published in:

2021

By:

Ferrannini, Ele;
Rosenstock, Julio

Publication type:

journal article

Erratum. Coronary Artery Disease and Type 2 Diabetes: A Proteomic Study. Diabetes Care 2020;43:843-851.

Published in:

2021

By:

Ferrannini, Giulia;
Manca, Maria Laura;
Magnoni, Marco;
Andreotti, Felicita;
Andreini, Daniele;
Latini, Roberto;
Maseri, Attilio;
Maggioni, Aldo P.;
Ostroff, Rachel M.;
Williams, Stephen A.;
Ferrannini, Ele

Publication type:

journal article

Insulin Resistance Is Associated With Enhanced Brain Glucose Uptake During Euglycemic Hyperinsulinemia: A Large-Scale PET Cohort.

Published in:

2021

By:

Rebelos, Eleni;
Bucci, Marco;
Karjalainen, Tomi;
Oikonen, Vesa;
Bertoldo, Alessandra;
Hannukainen, Jarna C.;
Virtanen, Kirsi A.;
Latva-Rasku, Aino;
Hirvonen, Jussi;
Heinonen, Ilkka;
Parkkola, Riitta;
Laakso, Markku;
Ferrannini, Ele;
Iozzo, Patricia;
Nummenmaa, Lauri;
Nuutila, Pirjo

Publication type:

journal article

Clinical Translation of Cardiovascular Outcome Trials in Type 2 Diabetes: Is There More or Is There Less Than Meets the Eye?

Published in:

2021

By:

Ferrannini, Ele;
Rosenstock, Julio

Publication type:

journal article

Erratum. Effects of Sustained Treatment With Lixisenatide on Gastric Emptying and Postprandial Glucose Metabolism in Type 2 Diabetes: A Randomized Controlled Trial. Diabetes Care 2020;43:1813-1821.

Published in:

2021

By:

Rayner, Christopher K.;
Watson, Linda E.;
Phillips, Liza K.;
Lange, Kylie;
Bound, Michelle J.;
Grivell, Jacqueline;
Wu, Tongzhi;
Jones, Karen L.;
Horowitz, Michael;
Ferrannini, Ele;
Tricò, Domenico;
Frascerra, Silvia;
Mari, Andrea;
Natali, Andrea

Publication type:

journal article

Mechanisms of Sodium-Glucose Cotransporter 2 Inhibition: Insights From Large-Scale Proteomics.

Published in:

2020

By:

Ferrannini, Ele;
Murthy, Ashwin C.;
Lee, Yong-ho;
Muscelli, Elza;
Weiss, Sophie;
Ostroff, Rachel M.;
Sattar, Naveed;
Williams, Stephen A.;
Ganz, Peter

Publication type:

journal article

Effects of Sustained Treatment With Lixisenatide on Gastric Emptying and Postprandial Glucose Metabolism in Type 2 Diabetes: A Randomized Controlled Trial.

Published in:

2020

By:

Rayner, Christopher K.;
Watson, Linda E.;
Phillips, Liza K.;
Lange, Kylie;
Bound, Michelle J.;
Grivell, Jacqueline;
Wu, Tongzhi;
Jones, Karen L.;
Horowitz, Michael;
Ferrannini, Ele;
Tricò, Domenico;
Frascerra, Silvia;
Mari, Andrea;
Natali, Andrea

Publication type:

journal article

Coronary Artery Disease and Type 2 Diabetes: A Proteomic Study.

Published in:

2020

By:

Ferrannini, Giulia;
Manca, Maria Laura;
Magnoni, Marco;
Andreotti, Felicita;
Andreini, Daniele;
Latini, Roberto;
Maseri, Attilio;
Maggioni, Aldo P;
Ostroff, Rachel M;
Williams, Stephen A;
Ferrannini, Ele

Publication type:

journal article

International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) Inhibitors.

Published in:

2019

By:

Danne, Thomas;
Garg, Satish;
Peters, Anne L.;
Buse, John B.;
Mathieu, Chantal;
Pettus, Jeremy H.;
Alexander, Charles M.;
Battelino, Tadej;
Ampudia-Blasco, F. Javier;
Bode, Bruce W.;
Cariou, Bertrand;
Close, Kelly L.;
Dandona, Paresh;
Dutta, Sanjoy;
Ferrannini, Ele;
Fourlanos, Spiros;
Grunberger, George;
Heller, Simon R.;
Henry, Robert R.;
Kurian, Martin J.

Publication type:

journal article

Empagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Left Ventricular Hypertrophy: A Subanalysis of the EMPA-REG OUTCOME Trial.

Published in:

2019

By:

Verma, Subodh;
Mazer, C. David;
Bhatt, Deepak L.;
Raj, Satish R.;
Yan, Andrew T.;
Verma, Atul;
Ferrannini, Ele;
Simons, Gudrun;
Jisoo Lee;
Zinman, Bernard;
George, Jyothis T.;
Fitchett, David;
Lee, Jisoo

Publication type:

Letter

How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial.

Published in:

Diabetes Care, 2018, v. 41, n. 2, p. 356, doi. 10.2337/dc17-1096

By:

Inzucchi, Silvio E.;
Zinman, Bernard;
Fitchett, David;
Wanner, Christoph;
Ferrannini, Ele;
Schumacher, Martin;
Schmoor, Claudia;
Ohneberg, Kristin;
Johansen, Odd Erik;
George, Jyothis T.;
Hantel, Stefan;
Bluhmki, Erich;
Lachin, John M.

Publication type:

Article

Diabetes Research and Care Through the Ages.

Published in:

2017

By:

Zinman, Bernard;
Skyler, Jay S.;
Riddle, Matthew C.;
Ferrannini, Ele

Publication type:

journal article

Renal Handling of Ketones in Response to Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 2 Diabetes.

Published in:

2017

By:

Ferrannini, Ele;
Baldi, Simona;
Frascerra, Silvia;
Astiarraga, Brenno;
Barsotti, Elisabetta;
Clerico, Aldo;
Muscelli, Elza

Publication type:

journal article

Response to Comment on Cefalu et al. Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors' Expert Forum. Diabetes Care 2016;39:1186-1201.

Published in:

2017

By:

Cefalu, William T.;
Bennett, Peter H.;
Ramachandran, Ambady;
Raz, Itamar;
Rosenstock, Julio;
Kahn, Steven E.;
Buse, John B.;
Tuomilehto, Jaakko;
Fleming, G. Alexander;
Ferrannini, Ele;
Gerstein, Hertzel C.

Publication type:

Letter

Response to Comment on Ferrannini et al. CV Protection in the EMPA-REG OUTCOME Trial: A "Thrifty Substrate" Hypothesis. Diabetes Care 2016;39:1108-1114.

Published in:

2016

By:

Ferrannini, Ele;
Mark, Michael;
Mayoux, Eric

Publication type:

Letter

CV Protection in the EMPA-REG OUTCOME Trial: A "Thrifty Substrate" Hypothesis. Diabetes Care 2016;39:1108-1114.

Published in:

2016

By:

Ferrannini, Ele;
Mark, Michael;
Mayoux, Eric

Publication type:

Opinion

Response to Comment on Ferrannini et al. Diabetes Care 2016;39:1108-1114. Comment on Mudaliar et al. Diabetes Care 2016;39:1115-1122.

Published in:

2016

By:

Ferrannini, Ele;
Mark, Michael;
Mayoux, Eric

Publication type:

Letter

Response to Comment on Rosenstock and Ferrannini. Euglycemic Diabetic Ketoacidosis: A Predictable, Detectable, and Preventable Safety Concern With SGLT2 Inhibitors. Diabetes Care 2015;38:1638-1642.

Published in:

2016

By:

Rosenstock, Julio;
Ferrannini, Ele

Publication type:

Letter

Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors' Expert Forum.

Published in:

2016

By:

Cefalu, William T.;
Buse, John B.;
Tuomilehto, Jaakko;
Fleming, G. Alexander;
Ferrannini, Ele;
Gerstein, Hertzel C.;
Bennett, Peter H.;
Ramachandran, Ambady;
Raz, Itamar;
Rosenstock, Julio;
Kahn, Steven E.

Publication type:

journal article

CV Protection in the EMPA-REG OUTCOME Trial: A "Thrifty Substrate" Hypothesis.

Published in:

2016

By:

Ferrannini, Ele;
Mark, Michael;
Mayoux, Eric

Publication type:

journal article

α-Hydroxybutyric Acid Is a Selective Metabolite Biomarker of Impaired Glucose Tolerance.

Published in:

2016

By:

Cobb, Jeff;
Eckhart, Andrea;
Motsinger-Reif, Alison;
Carr, Bernadette;
Groop, Leif;
Ferrannini, Ele

Publication type:

journal article

Effect of Bariatric Surgery on Adipose Tissue Glucose Metabolism in Different Depots in Patients With or Without Type 2 Diabetes.

Published in:

2016

By:

Dadson, Prince;
Landini, Linda;
Helmiö, Mika;
Hannukainen, Jarna C.;
Immonen, Heidi;
Honka, Miikka-Juhani;
Bucci, Marco;
Savisto, Nina;
Soinio, Minna;
Salminen, Paulina;
Parkkola, Riitta;
Pihlajamäki, Jussi;
Iozzo, Patricia;
Nuutila, Pirjo;
Ferrannini, Ele

Publication type:

journal article

Of microbes and men.

Published in:

2015

By:

Ferrannini, Ele

Publication type:

journal article

Energy Balance After Sodium-Glucose Cotransporter 2 Inhibition.

Published in:

Diabetes Care, 2015, v. 38, n. 9, p. 1730, doi. 10.2337/dc15-0355

By:

Ferrannini, Giulia;
Hach, Thomas;
Crowe, Susanne;
Sanghvi, Arjun;
Hall, Kevin D.;
Ferrannini, Ele

Publication type:

Article

Euglycemic Diabetic Ketoacidosis: A Predictable, Detectable, and Preventable Safety Concern With SGLT2 Inhibitors.

Published in:

2015

By:

Rosenstock, Julio;
Ferrannini, Ele

Publication type:

Opinion

Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach.

Published in:

Diabetes Care, 2015, v. 38, n. 1, p. 140, doi. 10.2337/dc14-2441

By:

Inzucchi, Silvio E.;
Bergenstal, Richard M.;
Buse, John B.;
Diamant, Michaela;
Ferrannini, Ele;
Nauck, Michael;
Peters, Anne L.;
Tsapas, Apostolos;
Wender, Richard;
Matthews, David R.

Publication type:

Article

Long-term safety and efficacy of empagliflozin, sitagliptin, and metformin: an active-controlled, parallel-group, randomized, 78-week open-label extension study in patients with type 2 diabetes.

Published in:

2013

By:

Ferrannini, Ele;
Berk, Andreas;
Hantel, Stefan;
Pinnetti, Sabine;
Hach, Thomas;
Woerle, Hans J;
Broedl, Uli C

Publication type:

journal article

Influence of apolipoproteins on the association between lipids and insulin sensitivity: a cross-sectional analysis of the RISC Study.

Published in:

2013

By:

Baldi, Simona;
Bonnet, Fabrice;
Laville, Martine;
Morgantini, Cecilia;
Monti, Lucilla;
Hojlund, Kurt;
Ferrannini, Ele;
Natali, Andrea;
RISC Investigators

Publication type:

journal article

Influence of Apolipoproteins on the Association Between Lipids and Insulin Sensitivity.

Published in:

Diabetes Care, 2013, v. 36, n. 12, p. 4125, doi. 10.2337/dc13-0682

By:

BALDI, SIMONA;
BONNET, FABRICE;
LAVILLE, MARTINE;
MORGANTINI, CECILIA;
MONTI, LUCILLA;
HOJLUND, KURT;
FERRANNINI, ELE;
NATALI, ANDREA

Publication type:

Article

Long-Term Safety and Efficacy of Empagliflozin, Sitagliptin, and Metformin.

Published in:

Diabetes Care, 2013, v. 36, n. 12, p. 4015, doi. 10.2337/dc13-0663

By:

FERRANNINI, ELE;
BERK, ANDREAS;
HANTEL, STEFAN;
PINNETTI, SABINE;
HACH, THOMAS;
WOERLE, HANS J.;
BROEDL, ULI C.

Publication type:

Article

Personalized management of hyperglycemia in type 2 diabetes: reflections from a Diabetes Care Editors' Expert Forum.

Published in:

2013

By:

Raz, Itamar;
Riddle, Matthew C;
Rosenstock, Julio;
Buse, John B;
Inzucchi, Silvio E;
Home, Philip D;
Del Prato, Stefano;
Ferrannini, Ele;
Chan, Juliana C N;
Leiter, Lawrence A;
Leroith, Derek;
Defronzo, Ralph;
Cefalu, William T

Publication type:

journal article

Personalized Management of Hyperglycemia in Type 2 Diabetes.

Published in:

2013

By:

RAZ, ITAMAR;
RIDDLE, MATTHEW C.;
ROSENSTOCK, JULIO;
BUSE, JOHN B.;
INZUCCHI, SILVIO E.;
HOME, PHILIP D.;
PRATO, STEFANO DEL;
FERRANNINI, ELE;
CHAN, JULIANA C. N.;
LEITER, LAWRENCE A.;
LEROITH, DEREK;
DEFRONZO, RALPH;
CEFALU, WILLIAM T.

Publication type:

Proceeding

Renal glucose handling: impact of chronic kidney disease and sodium-glucose cotransporter 2 inhibition in patients with type 2 diabetes.

Published in:

2013

By:

Ferrannini, Ele;
Veltkamp, Stephan A;
Smulders, Ronald A;
Kadokura, Takeshi

Publication type:

journal article

Renal Glucose Handling.

Published in:

Diabetes Care, 2013, v. 36, n. 5, p. 1260, doi. 10.2337/dc12-1503

By:

FERRANNINI, ELE;
VELTKAMP, STEPHAN A.;
SMULDERS, RONALD A.;
KADOKURA, TAKESHI

Publication type:

Article

Residual macrovascular risk in 2013: what have we learned?

Published in:

Cardiovascular Diabetology, 2014, v. 13, n. 1, p. 3, doi. 10.1186/1475-2840-13-26

By:

Fruchart, Jean-Charles;
Davignon, Jean;
Hermans, Michel P.;
Al-Rubeaan, Khalid;
Amarenco, Pierre;
Assmann, Gerd;
Barter, Philip;
Betteridge, John;
Bruckert, Eric;
Cuevas, Ada;
Farnier, Michel;
Ferrannini, Ele;
Fioretto, Paola;
Genest, Jacques;
Ginsberg, Henry N.;
Gotto Jr, Antonio M.;
Hu, Dayi;
Kadowaki, Takashi;
Kodama, Tatsuhiko;
Krempf, Michel

Publication type:

Article

Differential metabolomic signatures of declining renal function in Types 1 and 2 diabetes.

Published in:

Nephrology Dialysis Transplantation, 2021, v. 36, n. 10, p. 1859, doi. 10.1093/ndt/gfaa175

By:

Manca, Maria Laura;
Solini, Anna;
Haukka, Jani K;
Sandholm, Niina;
Forsblom, Carol;
Groop, Per-Henrik;
Ferrannini, Ele

Publication type:

Article